Lake Forest, CA, United States of America

Jesus Cardenas

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Rensselaer Polytechnic Institute. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jesus Cardenas. Retrieved from https://idiyas.com/inventor/jesus-cardenas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jesus Cardenas

Introduction

Jesus Cardenas is an accomplished inventor based in Lake Forest, CA (US). He has made significant contributions to the field of pharmaceuticals through his innovative work on controlled drug release mechanisms. With a total of 2 patents, Cardenas is recognized for his expertise in electrospun fibers.

Latest Patents

One of his latest patents focuses on the controlled drug release from electrospun fibers. This invention relates to the development of electrospun fiber scaffolds (EFSs) that facilitate the controlled release of an active pharmaceutical ingredient (API). This technology has the potential to enhance the efficacy of drug delivery systems.

Career Highlights

Jesus Cardenas is affiliated with Rensselaer Polytechnic Institute, where he continues to advance his research in the field of drug delivery. His work is pivotal in bridging the gap between material science and pharmaceutical applications.

Collaborations

He collaborates with notable colleagues such as Nicholas Schaub and Andrew Sante Fiumara, contributing to a dynamic research environment that fosters innovation.

Conclusion

Jesus Cardenas exemplifies the spirit of innovation in the pharmaceutical industry through his groundbreaking work on controlled drug release technologies. His contributions are paving the way for more effective drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…